In one study, KP was found to be abnormally activated in women with polycystic ovary syndrome (PCOS), with enhanced enzyme activities such as IDO, TDO, and KAT and elevated plasma Kyn, KYNA, and QUIN concentrations. The gene discussed is TDO2; the disease is polycystic ovary syndrome.